NOVEL PAENIBACILLUS SP. MBT213, FERMENTED GINSENG USING THE SAME AND COMPOSITION COMPRISING EXTRACT OF FERMENTED GINSENG USING THE SAME FOR PREVENTING OR TREATING ATOPIC DERMATITIS

摘要

The present invention relates to novel Paenibacillussp. MBT213 (microorganism deposition number KACC91831P) and to a fermented ginseng using the same. In addition, the present invention relates to a composition for preventing or treating atopic dermatitis which comprises extracts of fermented ginseng using Paenibacillussp. MBT213. A culture media of the Paenibacillussp. MBT213 (microorganism deposition number KACC91831P) has excellent effects which converts ginsenoside Rg1 inside the ginseng into Rd. In addition, the fermented ginseng or extract of the same which is manufactured by using the effects suppresses activities of MIP-1α (macrophage inflammatory protein-1α), IL-4 (interleukin-4) and IL-13 (interleukin-13) in order to be used as a medicine for treating or alleviating symptoms of various skin diseases such as atopic dermatitis.